Jul 26, 2024, 15:20
The interchangeability of PD-L1 scoring systems and assays in gastroesophageal cancer – EORTC
EORTC (European Organisation for Research and Treatment of Cancer) shared a post on X:
”Proud to share a new EORTC publication on RP-2321-GITCG ASPIRE, the first global study evaluating the interchangeability of programmed death-ligand 1 (PD-L1) scoring systems and assays in gastroesophageal cancer.
EORTC stomach cancer PD-L1 biomarker European initiative: the ASPIRE study protocol.
Authors: Angelica Petrillo, Lindsey Oudijk, Raghav Sundar, C. Daumer, J. Casas, D. D’haese, Murielle Mauer, Nicole van Grieken, Elizabeth Catherine Smyth, Markus Moehler.”
Source: EORTC/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 12, 2024, 23:10
Nov 12, 2024, 23:07
Nov 12, 2024, 22:58
Nov 12, 2024, 22:56
Nov 12, 2024, 22:50
Nov 12, 2024, 22:46
Nov 12, 2024, 22:43